Über diesen Podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
207 Folgen · health
On The Pen GLP-1 News
Über diesen Podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
Neue Folgen
- We’re Solving Obesity. Now Who Pays for It?2. Sept. · 25 Min.
- GLP-1 Coverage Is COLLAPSING in 202726. Aug. · 35 Min.
- $50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”18. Aug. · 45 Min.
- 200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study12. Aug. · 31 Min.
- Eli Lilly Earnings Call Recap: Retatrutide News7. Aug. · 1 Std. 00 Min.
- Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.4. Aug. · 19 Min.
- Retatrutide Biologic Battle: The Story Gets Bigger28. Juli · 21 Min.
- GLP-1 Showdown: Inside The High Stakes War over Patients22. Juli · 27 Min.
- Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know14. Juli · 32 Min.
- Compound GLP-1 Poll STUNS THE INTERNET!8. Juli · 16 Min.
podlinkr.com/de/on-the-pen-glp-1-news
Für ein Plakat oder eine Folie.